Status:
COMPLETED
Patient-Derived Organoids for Rectal Cancer
Lead Sponsor:
Duke University
Conditions:
Rectum Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.
Eligibility Criteria
Inclusion
- Inclusion
- Age ≥18 years old.
- Able to provide informed consent.
- Undergoing proctoscopy.
- Exclusion
- 1\. Patient not planned to receive neoadjuvant radiotherapy
Exclusion
Key Trial Info
Start Date :
September 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04371198
Start Date
September 18 2020
End Date
August 17 2022
Last Update
August 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Center
Durham, North Carolina, United States, 27710